Larry Norton
0000-0003-3701-9250
Publication & Citation Trends
Publications
0 total
Abstract PS2-02-30: Five-year survival outcomes after systemic therapy in older patients with early-stage triple negative breast cancer at memorial sloan kettering cancer center
Cited by 0
Semantic Scholar
Abstract PS5-02-23: Aretha trial: Safety run-in results of eribulin + evexomostat in metastatic triple-negative breast cancer with metabolic dysfunction
Cited by 0
Semantic Scholar
Abstract PD7-07: Three-year event-free survival from a phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative early stage/resectable breast cancer (ipilimumab/nivolumab cohort)
Cited by 0
Semantic Scholar
Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy
Cited by 1
Semantic Scholar
Abstract PS2-07-17: Characterizing circulating tumor cell (CTC) enumeration and phenotypic profiling in blood with synchronously obtained tissue in metastatic breast cancer (MBC) in TBCRC /AURORA US
Cited by 0
Semantic Scholar
Abstract PS4-03-18: Homologous Recombination Deficiency and DNA-Damage Response in Breast Invasive Lobular Carcinoma
Cited by 0
Semantic Scholar
292P Exploring HER3; A potentially targetable biomarker in rare metaplastic breast cancers
Cited by 0
Semantic Scholar
Abstract PS2-07-30: Structural Variants in Homologous Recombination Repair/DNA Damage Response Pathways as an Alternative Mechanism of Genomic Instability in Breast Cancer
Cited by 0
Semantic Scholar
Abstract P1-05-17: Structural Variants Affecting CDH1 in Breast Invasive Lobular Carcinoma
Cited by 0
Semantic Scholar
Genomic landscape of breast cancer in elderly patients
Cited by 1
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(247)
Cancer Treatment and Pharmacology
(215)
Cancer Genomics and Diagnostics
(192)
HER2/EGFR in Cancer Research
(184)
BRCA gene mutations in cancer
(129)
Affiliations
University of Vermont
Northwestern University
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
University of Southern California